RealSeq Biosciences, Inc. a privately held biotech company located in Santa Cruz, California specializes in developing innovative technologies for biomarker discovery, liquid biopsy and single cell analysis in the fields of cancer and infectious diseases.

Founded by Sergio-Barberan-Soler, Ph.D. in 2019, the RealSeq Biosciences’ core technologies originate with Dr. Barberan-Soler’s NIH (NHGRI) SBIR-funded research in the areas of novel small RNA NGS library construction technologies and single cell analysis.

The  RealSeq® small RNA sequencing products and NGS services are sold worldwide directly and through distribution partnerships.  Products include RealSeq®-AC for small RNA analysis from tissues and cells and RealSeq®-biofluids for small RNA analysis directly from biofluid samples. 

The company’s development pipeline includes diagnostic platforms for liquid biopsy (RealSeq®-T) as well as single cell analysis of small RNAs (RealSeq®-SC).